(S)-6-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride, 95.0%, 250mg

4-(2-Oxo-1,3-oxazinan-3-yl)benzoic acid, 95%, 100mg

3-[(E)-Hydroxyimino]-4,7,7-trimethyl-bicyclo[2.2.1]heptane-1-carboxylic acid, 95.0%, 250mg

Sapitinib, 99.93%, 10mg

tert-Butyl (4-iodobutyl)carbamate, 97.0%, 5g

ZL-Aspartic Acid, PEPTIPURE®, min. 98.5%, for biochemistry, 25 g, plastic packaging.

1-(Prop-2-yn-1-yl)piperidin-3-amine dihydrochloride, 100mg

5-fluoro-2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 5g

(S)-4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid compound with benzenesulfonic acid (1:1), 98%, 50mg

3-Hydroxy-N-(3-nitrophenyl)-2-naphthalenecarboxamide, 98%, 100g

tert-Butyl 2-(cyanomethyl)piperazine-1-carboxylate, 98%, 100mg

Methyl-5-norbornene-2,3-dicarboxylic Anhydride (mixture of isomers)>80.0%(GC)25g

3-(Isopropylsulfonyl)azetidine hydrochloride, 98%, 100mg